LAMIVUDINE - 60429-353-60 - (lamivudine)

Alphabetical Index


Drug Information of LAMIVUDINE

Product NDC: 60429-353
Proprietary Name: LAMIVUDINE
Non Proprietary Name: lamivudine
Active Ingredient(s): 150    mg/1 & nbsp;   lamivudine
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of LAMIVUDINE

Product NDC: 60429-353
Labeler Name: Golden State Medical Supply, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA091606
Marketing Category: ANDA
Start Marketing Date: 20111202

Package Information of LAMIVUDINE

Package NDC: 60429-353-60
Package Description: 60 TABLET, FILM COATED in 1 BOTTLE (60429-353-60)

NDC Information of LAMIVUDINE

NDC Code 60429-353-60
Proprietary Name LAMIVUDINE
Package Description 60 TABLET, FILM COATED in 1 BOTTLE (60429-353-60)
Product NDC 60429-353
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name lamivudine
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20111202
Marketing Category Name ANDA
Labeler Name Golden State Medical Supply, Inc.
Substance Name LAMIVUDINE
Strength Number 150
Strength Unit mg/1
Pharmaceutical Classes Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]

Complete Information of LAMIVUDINE


General Information